Top Stocks To Buy For 2019


Angel Broking’s currency report on EURINR

EURUSD depreciated by 0.28 percent yesterday while EURINR appreciated by 0.21 percent during the same time frame. German WPI came in at 0.3 percent for Aug’18 against market expectations of 0.2 percent. Euro zone manufacturing PMI came in line with market expectations at 54.6 for Aug’18. Euro zone CPI came in line with market expectation sat 2 percent for Aug’18. Meanwhile, in Mario Draghi’s latest speech he expects underlying inflation in Euro area rise to rise in the coming future.


OUTLOOK

EURINR is expected to appreciate in today’s session.

Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.

Read More

Top Stocks To Buy For 2019: Unilever N.V. (UNLVF)

Advisors’ Opinion:

  • [By ]

    In recent weeks, Procter & Gamble (PG) has received a couple of downgrades following its Q3 FY2018 results announcement. In contrast, its peer in the consumer products space, Unilever (UL)(UN)(OTCPK:UNLNF)(OTCPK:UNLYF)(OTCPK:UNLVF), was upgraded by UBS in late March. Investors also cheered the announcement of a fresh €6 billion ($7.4 billion) stock buyback program and the raising of its quarterly dividend by 8% to €0.3872/share from €0.3585. In 2017, Unilever has already completed a €5 billion share buyback programme.

Top Stocks To Buy For 2019: Marcus & Millichap, Inc.(MMI)


Advisors’ Opinion:

  • [By Motley Fool Transcribers]

    Marcus & Millichap Inc  (NYSE:MMI)Q4 2018 Earnings Conference CallFeb. 20, 2019, 5:00 p.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By Shane Hupp]

    Marcus & Millichap (NYSE:MMI) was downgraded by analysts at JMP Securities from an “outperform” rating to a “market perform” rating in a report issued on Wednesday, Marketbeat reports.

  • [By Logan Wallace]

    Marcus & Millichap Inc (NYSE:MMI) major shareholder Phoenix Investments Holdings L sold 3,000 shares of Marcus & Millichap stock in a transaction that occurred on Monday, July 30th. The shares were sold at an average price of $40.27, for a total transaction of $120,810.00. Following the completion of the transaction, the insider now directly owns 16,532,215 shares in the company, valued at approximately $665,752,298.05. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Major shareholders that own more than 10% of a company’s shares are required to disclose their sales and purchases with the SEC.

Top Stocks To Buy For 2019: Motorola Solutions, Inc.(MSI)


Advisors’ Opinion:

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Motorola Solutions (MSI)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Logan Wallace]

    Norinchukin Bank The boosted its stake in shares of Motorola Solutions Inc (NYSE:MSI) by 16.8% during the first quarter, HoldingsChannel.com reports. The firm owned 15,755 shares of the communications equipment provider’s stock after purchasing an additional 2,263 shares during the quarter. Norinchukin Bank The’s holdings in Motorola Solutions were worth $1,659,000 as of its most recent filing with the Securities & Exchange Commission.

  • [By Ethan Ryder]

    Motorola Solutions (NYSE:MSI) issued an update on its FY 2019 earnings guidance on Thursday morning. The company provided earnings per share guidance of $7.55-7.70 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $7.56. The company issued revenue guidance of $7.784-7.857 billion, compared to the consensus revenue estimate of $7.7 billion.Motorola Solutions also updated its FY19 guidance to $7.55-7.70 EPS.

  • [By Joseph Griffin]

    Motorola Solutions (NYSE:MSI) has been given a $137.00 price objective by stock analysts at Credit Suisse Group in a report released on Monday. The firm presently has a “buy” rating on the communications equipment provider’s stock. Credit Suisse Group’s price objective indicates a potential upside of 11.39% from the stock’s current price.

Top Stocks To Buy For 2019: Imprimis Pharmaceuticals, Inc.(IMMY)


Advisors’ Opinion:

  • [By Stephan Byrd]

    Headlines about Imprimis Pharmaceuticals (NASDAQ:IMMY) have been trending positive recently, according to Accern Sentiment Analysis. Accern identifies negative and positive press coverage by monitoring more than 20 million blog and news sources in real time. Accern ranks coverage of companies on a scale of negative one to one, with scores nearest to one being the most favorable. Imprimis Pharmaceuticals earned a daily sentiment score of 0.25 on Accern’s scale. Accern also gave media headlines about the specialty pharmaceutical company an impact score of 47.393314841388 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the company’s share price in the immediate future.

  • [By Lisa Levin] Gainers
    Boot Barn Holdings, Inc. (NYSE: BOOT) rose 15.6 percent to $25.40 in pre-market trading after the company reported upbeat results for its fourth quarter and issued strong first-quarter earnings guidance.
    Abaxis, Inc. (NASDAQ: ABAX) rose 15.3 percent to $82.75 in pre-market trading. Zoetis Inc. (NYSE: ZTS) announced plans to acquire Abaxis for $83 per share in cash.
    Calumet Specialty Products Partners, L.P. (NASDAQ: CLMT) rose 12.6 percent to $8.95 in pre-market trading after reporting Q1 results.
    Micro Focus International plc (NYSE: MFGP) shares rose 8.8 percent to $18.59 in the pre-market trading session after the company issued strong revenue forecast for the first fiscal half of 2018.
    HC2 Holdings, Inc. (NASDAQ: HCHC) rose 5.6 percent to $6.60 in pre-market trading.
    Eleven Biotherapeutics, Inc. (NASDAQ: EBIO) shares rose 5.3 percent to $2.79 in pre-market trading. Eleven Biotherapeutics posted a Q1 loss of $0.11 per share.
    Imprimis Pharmaceuticals Inc (NASDAQ: IMMY) rose 5.2 percent to $2.52 in pre-market trading after reporting a first-quarter sales beat.
    Red Violet, Inc. (NASDAQ: RDVT) rose 4.1 percent to $10.35 in pre-market trading after climbing 75.31 percent on Tuesday.
    Xenon Pharmaceuticals Inc (NASDAQ: XENE) rose 3.8 percent to $6.90 in pre-market trading. The stock rose over 10 percent Tuesday after reporting its Phase 1 clinical update on XEN901 demonstrated a favorable PK profile.
    Sea Limited (NYSE: SE) rose 3.5 percent to $11.01 in pre-market trading after reporting Q1 results.
    Teva Pharmaceutical Industries Limited (NYSE: TEVA) shares rose 3.4 percent to $20.98 in pre-market trading after Buffett's Berkshire more than doubled its stake in Teva.
    China Internet Nationwide Financial Services Inc. (NASDAQ: CIFS) shares rose 3.7 percent to $31.30 in pre-market trading after the company reported results for its fourth quarter.
    PetIQ Inc (NASDAQ: PETQ) shares rose 3.4 percent to $20.00 in pre-market t
  • [By Lisa Levin] Gainers
    Blink Charging Co. (NASDAQ: BLNK) shares jumped 26.5 percent to $6.9042. Blink Charging reported Q1 net income of $2.2 million, versus a year-ago net loss of $3.1 million.
    Eleven Biotherapeutics, Inc. (NASDAQ: EBIO) shares climbed 17.4 percent to $3.11. Eleven Biotherapeutics posted a Q1 loss of $0.11 per share.
    Flanigan's Enterprises, Inc. (NYSE: BDL) shares jumped 17 percent to $27.97 following Q2 results. Flanigan's Enterprises posted Q2 earnings of $0.75 per share on sales of $29.456 million.
    Borqs Technologies, Inc. (NASDAQ: BRQS) rose 15.8 percent to $8.05 after reporting Q1 results.
    Abaxis, Inc. (NASDAQ: ABAX) jumped 15.3 percent to $82.75. Zoetis Inc. (NYSE: ZTS) announced plans to acquire Abaxis for $83 per share in cash.
    21Vianet Group, Inc. (NASDAQ: VNET) gained 15.1 percent to $6.33.
    Gemphire Therapeutics Inc. (NASDAQ: GEMP) rose 13.8 percent to $6.27.
    Enphase Energy, Inc. (NASDAQ: ENPH) gained 12.8 percent to $5.98. H.C. Wainwright initiated coverage on Enphase Energy with a Buy rating.
    PetIQ Inc (NASDAQ: PETQ) shares surged 12.1 percent to $21.68 after reporting a first-quarter sales beat.
    NF Energy Saving Corporation (NASDAQ: NFEC) climbed 11.6 percent to $2.399.
    Allied Healthcare Products, Inc. (NASDAQ: AHPI) surged 11.4 percent to $3.0643.
    Boot Barn Holdings, Inc. (NYSE: BOOT) gained 11.1 percent to $24.40 after the company reported upbeat results for its fourth quarter and issued strong first-quarter earnings guidance.
    Ascena Retail Group, Inc. (NASDAQ: ASNA) rose 10.9 percent to $3.16.
    Sea Limited (NYSE: SE) gained 10.1 percent to $11.71 after reporting Q1 results.
    GEE Group, Inc. (NYSE: JOB) climbed 7.9 percent to $2.61 following Q2 results.
    The ONE Group Hospitality, Inc. (NASDAQ: STKS) gained 7.6 percent to $2.41 after reporting Q1 results.
    Biolinerx Ltd/S ADR (NASDAQ: BLRX) rose 7.3 percent to $0.8798 after the company was granted a patent approval. The clinical-st

Top Stocks To Buy For 2019: OncoSec Medical Incorporated(ONCS)


Advisors’ Opinion:

  • [By Logan Wallace]

    Here are some of the headlines that may have effected Accern Sentiment’s rankings:

    Get OncoSec Medical alerts:

    OncoSec Medical (ONCS) Given Buy Rating at Dawson James (americanbankingnews.com) OncoSec Presents Update from Triple Negative Breast Cancer Program at 3rd Global Insight Conference on Breast Cancer (finance.yahoo.com) OncoSec appoints Sara M. Bonstein as CFO and COO (seekingalpha.com) Oncosec Medical (ONCS) Appoints Sara M. Bonstein as CFO and COO (streetinsider.com) OncoSec Appoints Sara M. Bonstein as Chief Financial Officer and Chief Operating Officer (finance.yahoo.com)

    ONCS stock traded down $0.02 during trading on Thursday, reaching $1.28. The company’s stock had a trading volume of 367,800 shares, compared to its average volume of 916,959. OncoSec Medical has a 1 year low of $0.88 and a 1 year high of $2.95. The firm has a market capitalization of $68.05 million, a PE ratio of -1.21 and a beta of 2.98.

  • [By Stephan Byrd]

    HC Wainwright set a $4.00 price target on OncoSec Medical (NASDAQ:ONCS) in a research report released on Tuesday. The firm currently has a buy rating on the biotechnology company’s stock.

  • [By Max Byerly]

    OncoSec Medical Inc (NASDAQ:ONCS) traded up 5.9% on Wednesday . The stock traded as high as $1.45 and last traded at $1.43. 506,563 shares changed hands during mid-day trading, a decline of 31% from the average session volume of 730,660 shares. The stock had previously closed at $1.35.